galactose has been researched along with diclofenac in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreazza, IF; Bresolin, TM; Ganter, JL; Ughini, F | 1 |
| Biemel, KM; Mueller, D; Müller-Vieira, U; Noor, F; Nüssler, AK; Tascher, G | 1 |
| Boatto, G; Burrai, L; Chegaev, K; Cristiano, C; De Caro, C; Gazzano, E; Lazzarato, L; Magliocca, S; Marabello, D; Marini, E; Nieddu, M; Riganti, C; Rimoli, MG; Rolando, B; Russo, R; Sodano, F | 1 |
| Ahuja, M; Verma, S | 1 |
| Arzik, S; Güneri, T; Kantarci, G; Karasulu, HY; Ozgüney, I | 1 |
1 trial(s) available for galactose and diclofenac
| Article | Year |
|---|---|
Comparison of different water/oil microemulsions containing diclofenac sodium: preparation, characterization, release rate, and skin irritation studies.
Topics: 1-Propanol; 2-Propanol; Administration, Cutaneous; Anti-Inflammatory Agents, Non-Steroidal; Cetomacrogol; Chemistry, Pharmaceutical; Diclofenac; Drug Carriers; Drug Compounding; Electric Conductivity; Emulsions; Erythema; Ethanol; Female; Hexoses; Humans; Hydrogen-Ion Concentration; Kinetics; Male; Models, Chemical; Particle Size; Skin; Skin Irritancy Tests; Solubility; Soybean Oil; Surface-Active Agents; Technology, Pharmaceutical; Viscosity; Water | 2007 |
4 other study(ies) available for galactose and diclofenac
| Article | Year |
|---|---|
Evaluation of xanthan and highly substituted galactomannan from M. scabrella as a sustained release matrix.
Topics: Delayed-Action Preparations; Diclofenac; Galactose; Hydrogen-Ion Concentration; Mannans; Mimosa; Polysaccharides, Bacterial; Seeds; Solubility | 2004 |
Biotransformation of diclofenac and effects on the metabolome of primary human hepatocytes upon repeated dose exposure.
Topics: 3-Hydroxybutyric Acid; Biotransformation; Cells, Cultured; Cytochrome P-450 Enzyme System; Diclofenac; Drug-Related Side Effects and Adverse Reactions; Galactose; Glucose; Hepatocytes; Humans; Lactic Acid; Liver; Metabolic Detoxication, Phase I; Metabolic Detoxication, Phase II; Metabolome | 2012 |
Aceclofenac-Galactose Conjugate: Design, Synthesis, Characterization, and Pharmacological and Toxicological Evaluations.
Topics: Acute Pain; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Caco-2 Cells; Carrageenan; Diclofenac; Disease Models, Animal; Drug Carriers; Drug Compounding; Edema; Galactose; Gastric Mucosa; Humans; Hydrolysis; Intestinal Mucosa; Male; Mice; Permeability; Platelet Aggregation; Prodrugs; Solubility; Stomach Ulcer | 2018 |
Carboxymethyl modification of Cassia obtusifolia galactomannan and its evaluation as sustained release carrier.
Topics: Calorimetry, Differential Scanning; Cassia; Delayed-Action Preparations; Diclofenac; Drug Carriers; Drug Delivery Systems; Drug Liberation; Galactose; Mannans; Molecular Structure; Plant Gums; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2020 |